To determine the efficacy of photodynamic therapy (PDT) with verteporfin for polypoidal choroidal vasculopathy (PCV).
PDT was performed in 35 patients (35 eyes) with PCV. We evaluated the number of treatments and compared visual acuity (VA), ophthalmological findings, and changes in polypoidal lesions and branching vascular networks by measuring lesion diameters using Heidelberg retina angiography before PDT, and then every 3 months for 1 year after PDT.
The mean annual number of treatment sessions was 2.2. VA was improved or maintained in 80% of the patients. Retinal pigment epithelium detachment, retinal detachment, hemorrhage, and/or exudates disappeared in 69%, and leakage resolved in 74% of the patients. Polypoidal lesions disappeared completely on indocyanine green angiography in 83% of the patients. All branching vascular networks persisted. Polypoidal lesions had recurred at the termini of the remaining branching vascular networks at 9 months after the first PDT in two eyes and at 12 months in one eye.
PDT with verteporfin for PCV appears to improve or maintain VA for the first posttreatment year. Approximately 70% of PCV cases showed improved ophthalmoscopic findings. However, as polypoidal lesions recur after PDT in some cases, further study is needed to confirm the long-term efficacy of PDT for PCV. Jpn J Ophthalmol 2007;51:270–277 @ Japanese Ophthalmological Society 2007
Spaide, RF, Yannuzzi, LA, Slakter, JS, et al. 1995Indocyanine green video angiography of idiopathic polypoidal vasculopathyRetina15100110PubMedCrossRefGoogle Scholar
Lee, SC, Seong, YS, Kim, SS, et al. 2004Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the maculaOphthalmologica218193201PubMedCrossRefGoogle Scholar
Chan, WM, Lam, DS, Lai, TY, et al. 2004Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case seriesOphthalmology11115761584PubMedCrossRefGoogle Scholar
Hussain, N, Hussain, A, Natarajan, S 2005Role of photodynamic therapy in polypoidal choroidal vasculopathyIndian J Ophthalmol53101104PubMedGoogle Scholar
Silva, RM, Figueira, J, Cachulo, ML, et al. 2005Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfinGraefes Arch Clin Exp Ophthalmol243973979PubMedCrossRefGoogle Scholar
Japanese Study Group of Polypoidal Choroidal Vasculopathy2005Criteria for diagnosis of polypoidal choroidal vasculopathy (in Japanese with English abstract)Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc)109417427Google Scholar
Sho, K, Takahashi, K, Yamada, H, et al. 2003Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristicsArch Ophthalmol12113921396PubMedCrossRefGoogle Scholar
Chan, W-M, Lai, TYY, Tano, Y, Liu, DTL, Li, KKW, Lam, DSC 2006Photodynamic therapy in macular diseases of Asian populations: when East meets WestJpn J Ophthalmol50161169PubMedCrossRefGoogle Scholar
Rosenblatt, BJ, Shah, GK, Blinder, K 2005Photodynamic therapy with verteporfin for peripapillary choroidal neovascularizationRetina253337PubMedCrossRefGoogle Scholar
Schlotzer-Schrehardt, U, Viestenz, A, Naumann, GO, et al. 2002Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyesGraefes Arch Clin Exp Ophthalmol240748757PubMedGoogle Scholar
Yuzawa, M, Mori, R, Haruyama, M 2003A study of laser photocoagulation for polypoidal choroidal vasculopathyJpn J Ophthalmol47379384PubMedCrossRefGoogle Scholar